TABLE 2.

Baby-MONITOR Subcomponents by AAP Level

Outcome Measure	Level	N	Mean	SD	Range	P	Type III P
Antenatal steroid	2	7	−1.12	1.54	–2.49 to 1.54	.036	.002
	3	86	0.32	2.91	–10.9 to 5.76	.0008a
	4	15	2.7	3.4	–2.39 to 7.46	Ref
	Overall	108	0.85	3.19	–10.9 to 7.46
No hypothermia on admission	2	7	−2.86	3.23	–7.34 to 2.61	.124	.286
	3	87	1.2	4.66	–13.02 to 9.49	.466
	4	20	2.03	6.76	–8.2 to 11.02	Ref
	Overall	114	1.32	5.37	–13.02 to 11.02
Any human milk at discharge	2	7	−0.46	2.42	–4.2 to 4.41	.430	.092
	3	87	−0.44	4.06	–12.8 to 6.78	.030
	4	20	1.6	5.26	–7.75 to 10.98	Ref
	Overall	114	0.13	4.49	–12.79 to 10.98
Timely eye examination	2	7	−1.71	1.88	–4.63 to 1.14	.099	.248
	3	87	0.71	2.44	–8.21 to 5.32	.853
	4	20	0.81	2.88	–3.39 to 5.12	Ref
	Overall	114	0.67	2.59	–8.21 to 5.32
Survival	2	7	1.1	1.38	–1.19 to 2.75	.659	.083
	3	87	−0.11	1.78	–3.61 to 4.33	.045
	4	20	0.64	1.73	–1.64 to 4.12	Ref
	Overall	114	0.13	1.8	–3.61 to 4.33
No chronic lung disease	2	7	−0.84	1.81	–3.51 to 2.17	.583	.792
	3	87	0.35	3.08	–5.96 to 8.11	.800
	4	20	0.18	3.32	–6.86 to 4.76	Ref
	Overall	114	0.27	3.13	–6.86 to 8.11
No health care–associated infection	2	7	−0.67	2.79	–5.67 to 2.22	.967	.040
	3	87	0.65	2.58	–6.42 to 6.81	.014a
	4	20	−0.73	2.65	–5.86 to 4.13	Ref
	Overall	114	0.22	2.68	–6.42 to 6.81
No pneumothorax	2	7	1.16	0.68	–0.39 to 2.19	.012	<.0001a
	3	87	0.48	1.56	–3.15 to 3.74	<.001a
	4	20	−1.14	1.51	–3.15 to 2.8	Ref
	Overall	114	0.05	1.7	–3.15 to 3.74
High growth velocity	2	7	0.93	2.67	–2.3 to 4.47	.215	.006
	3	87	0.71	4.23	–10.92 to 10.28	.002a
	4	20	−2.12	4.0	–9.1 to 6.28	Ref
	Overall	114	−0.08	4.32	–10.92 to 10.28

^aStatistical significance after Bonferroni adjustment for multiple testing.